Manchester Science Partnerships (MSP), the UK’s leading science and technology park operator have unveiled plans for yet another expansion of the Citylabs biomedical research centre.
In a joint partnership with Central Manchester University Hospitals NHS Foundation Trust (CMFT) MSP will create Citylabs 2.0 and Citylabs 3.0 on the CMFT campus, in the heart of Manchester’s Innovation District.
If the £60 million investment plans are approved, the existing Citylabs 1.0 will be joined by two new developments; Citylabs 2.0 and Citylabs 3.0.
This additional space will provide the growth of biomedical companies and the co-creation of new health products, in collaboration with the NHS and academia.
The completion of both Citylabs 2.0 and Citylabs 3.0 is expected to bring additional economic growth of over £100 million and more than 750 jobs to the city.
Rowena Burns, Chief Executive of Manchester Science Partnerships said: “Our investment will help create fresh ideas, partnerships and scientific discovery. Above all, Manchester and the North West offer investors outstanding access to talent, knowledge and clinical facilities”.
Chris Oglesby, Chairman of Manchester Science Partnerships added: “Manchester’s excellent connectivity, universities and talent pool, combined with its spirit of enterprise means the city is well placed to thrive in the coming years and we are determined to be at the heart of this journey”.
Citylabs 2.0 and 3.0 will be located on the corner of Oxford Road and Hathersage Road, opposite Whitworth Park, at the southern gateway to the University of Manchester.
Subject to planning permission being granted, the £25 million Citylabs 2.0 development construction work will begin in spring 2017, with completion expected in summer 2018.
Citylabs 3.0 will be located in Old Saint Mary’s Hospital, an existing listed Victorian building. Construction is due to begin during the summer in 2018 and is expected to be completed in 2020.